Does PSA screening reduce prostate cancer mortality?
Vis
André N
AN
Department of Pathology and Urology, Josephine Nefkens Institute, Erasmus University, Rotterdam, The Netherlands. viscus@wanadoo.nl
D000368:Aged; D015331:Cohort Studies; D023381:Endpoint Determination; D016021:Epidemiologic Studies; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009026:Mortality / Q000639:trends; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000401:mortality*
D017430:Prostate-Specific Antigen